Drug recall · July 15, 2020
Nystatin Oral Suspension recall
Why: Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Nystatin Oral Suspension, USP 100,000 units per mL, Bubblegum Flavored, 16 fl. oz. bottle (480 mL), Shake Well Before Using, Rx Only, Manufactured by: VistaPharm, Inc., Largo, FL 33771, NDC 66689-008-16.
- Lots / codes
Lot # 639000, Exp. 10/31/2021
- Quantity
- 14,760 bottles
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- United States including Puerto Rico
- Initiated
- June 23, 2020 · Voluntary: Firm initiated
- Classified
- July 8, 2020
- Reported
- July 15, 2020
- Ended
- September 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.